Non-Hodgkin lymphoma laboratory tests

Revision as of 18:50, 20 January 2019 by Preeti Singh (talk | contribs)
Jump to navigation Jump to search

Non-Hodgkin lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Non-Hodgkin's Lymphoma

Differentiating Non-Hodgkin Lymphoma from Other Diseases
Differentiating Types of Non-Hodgkin's Lymphoma

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Non-Hodgkin lymphoma laboratory tests On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non-Hodgkin lymphoma laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non-Hodgkin lymphoma laboratory tests

CDC on Non-Hodgkin lymphoma laboratory tests

Non-Hodgkin lymphoma laboratory tests in the news

Blogs on Non-Hodgkin lymphoma laboratory tests

Directions to Hospitals Treating Non-Hodgkin lymphoma

Risk calculators and risk factors for Non-Hodgkin lymphoma laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [3]

Overview

Laboratory tests for non-Hodgkin lymphoma include complete blood count (CBC), blood chemistry studies, HIV blood test, and hepatitis B blood test.

Laboratory Tests

Laboratory tests for non-Hodgkin lymphoma include the following:[1][2][3]

Complete Blood Count

  • In early stage of the disease the complete blood count (CBC) may be normal.
  • Anemia may be seen secondary to involvement of bone marrow, autoimmune hemolysis and bleeding.
  • Thrombocytopenia, leukopenia, or pancytopenia may be seen after bone marrow infiltration or autoimmune cytopenias.
  • Lymphocytosis with circulating malignant cells seen in low grade lymphomas.
  • Thrombocytosis may be seen as a paraneoplastic syndrome.

Blood Chemistry Studies

  • Elevated lactate dehydrogenase (LDH) correlates with poor prognosis.
  • Liver function test (LFT) results may be abnormal secondary to hepatic involvement.
  • Hypercalcemia may be seen in patients with acute form of adult T-cell lymphoma-leukemia (ATLL).

Other Studies

  • Increased levels of beta2-microglobulin level may be seen, which correlate with a poor prognosis.
  • A positive Coombs test may be positive.
  • Hypogammaglobulinemia may be present.
  • HIV viral load and the antibody titre may be elevated.
  • HTLV-1 serology should be obtained in patients with ATLL.
  • HbsAg and Hep B antibody titre must be obtained.

References

  1. Sandlund JT (2015). "Non-Hodgkin Lymphoma in Children". Curr Hematol Malig Rep. 10 (3): 237–43. doi:10.1007/s11899-015-0277-y. PMID 26174528.
  2. Shankland KR, Armitage JO, Hancock BW (2012). "Non-Hodgkin lymphoma". Lancet. 380 (9844): 848–57. doi:10.1016/S0140-6736(12)60605-9. PMID 22835603.
  3. Hingorjo MR, Syed S (2008). "Presentation, staging and diagnosis of lymphoma: a clinical perspective". J Ayub Med Coll Abbottabad. 20 (4): 100–3. PMID 19999217.